Treo Ventures

Treo Ventures is a venture capital firm established in 2018 focusing on investing in breakthrough medical device and digital health innovations targeting large unmet clinical needs. The firm invests primarily in companies based in the US and Europe, leveraging offices in Silicon Valley and Ireland. Treo Ventures supports companies at various stages, from early stage with proven feasibility to later stage scaling for commercialization. Their portfolio includes companies developing novel neuromodulation therapies, ultrasound-based treatments, implantable medical devices, and cardiovascular technologies. Treo Ventures also operates NuXcel, a global medical device accelerator. The team brings over 90 years of combined healthcare investing and operational experience, with a strong track record of building successful healthcare companies and active involvement in portfolio companies' growth and commercialization.